{"title":"为更健康的未来做准备——当前艾滋病毒药理学预防实践的简明更新","authors":"S. Steyn, De Wet Wolmarans, L. Brand","doi":"10.36303/sagp.2020.2.0015","DOIUrl":null,"url":null,"abstract":"Pre-exposure prophylaxis (PrEP) refers to the use of antiretroviral drugs to prevent one from acquiring human immunodeficiency virus (HIV) infection when engaging in high-risk sexual behaviour. Adequate PrEP initiation is key in the clinical outcome and survival of not only vulnerable and high-risk populations, but also to ensure that a society which is free of HIV, is built.","PeriodicalId":21867,"journal":{"name":"South African General Practitioner","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PrEPping for a healthier future – a concise update of current pharmacological HIV-prophylaxis practices\",\"authors\":\"S. Steyn, De Wet Wolmarans, L. Brand\",\"doi\":\"10.36303/sagp.2020.2.0015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pre-exposure prophylaxis (PrEP) refers to the use of antiretroviral drugs to prevent one from acquiring human immunodeficiency virus (HIV) infection when engaging in high-risk sexual behaviour. Adequate PrEP initiation is key in the clinical outcome and survival of not only vulnerable and high-risk populations, but also to ensure that a society which is free of HIV, is built.\",\"PeriodicalId\":21867,\"journal\":{\"name\":\"South African General Practitioner\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African General Practitioner\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36303/sagp.2020.2.0015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African General Practitioner","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36303/sagp.2020.2.0015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PrEPping for a healthier future – a concise update of current pharmacological HIV-prophylaxis practices
Pre-exposure prophylaxis (PrEP) refers to the use of antiretroviral drugs to prevent one from acquiring human immunodeficiency virus (HIV) infection when engaging in high-risk sexual behaviour. Adequate PrEP initiation is key in the clinical outcome and survival of not only vulnerable and high-risk populations, but also to ensure that a society which is free of HIV, is built.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
